Open AccessExpected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
Author(s) -
Alexia Kieffer,
Matthieu Beuvelet,
Aditya Sardesai,
Robert Musci,
Sandra Milev,
Julie Roïz,
Jason K. H. Lee
Publication year - 2022
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiac216
Subject(s) - immunization , medicine , respiratory tract infections , palivizumab , respiratory system , virology , virus , respiratory illness , pneumovirinae , respiratory tract , immunology , pediatrics , antibody , viral disease , paramyxoviridae
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom